AVS
Angie Volk currently serves as the VP of Business Development at Amplitude Vascular Systems, leading the commercial strategy and execution for innovative Intravascular Lithotripsy technology. Prior to this role, Angie held the position of US VP Sales in the Medical Solutions Division at 3M, overseeing a large team of sales associates in diverse care settings. Angie's experience also includes serving as US VP of Sales for Urology & Critical Care at BD, managing multiple integrated businesses and a significant revenue base. At Boston Scientific, Angie held several key positions, including Vice President of Sales Strategy & Operations, where contributions led to advancing interventional cardiology solutions. Academic credentials include an MBA in Marketing from the University of Minnesota and a BS in Mechanical Engineering from North Dakota State University.
This person is not in any teams
This person is not in any offices
AVS
AVS is an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2018 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer at AVS. They are redefining interventional therapy for severely calcified lesions with their Pulse IVL System, which uses a novel pulsatile mechanism of action to shatter calcium and expand narrowed vessels, all with a single device.